About Steve Biko Academic Hospital; Oncology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
7
Clinical Trials at Steve Biko Academic Hospital; Oncology
During the past decade, Steve Biko Academic Hospital; Oncology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on
average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Vemurafenib in Participants With Metastatic Melanoma
2011-03-01
2016-02-24
Completed
3,219
A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer
2011-11-08
2028-11-30
Active, not recruiting
4,804
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
2012-05-17
2020-02-19
Completed
2,577
A Study of Subcutaneous Versus Intravenous MabThera/Rituxan (Rituximab) in Combination With CHOP Chemotherapy in Patients With Previously Untreated CD20-Positive Diffuse Large B-Cell Lymphoma
2012-08-24
2016-09-16
Completed
572
Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma
2016-06-30
2023-06-30
Active, not recruiting
1,214
Cobimetinib (Targeted Therapy) Plus Atezolizumab (Immunotherapy) in Participants With Advanced Melanoma Whose Cancer Has Worsened During or After Treatment With Previous Immunotherapy and Atezolizumab Monotherapy in Participants With Previously Untreated Advanced Melanoma
2017-06-20
2020-09-21
Completed
155
A Study of Atezolizumab (Anti-Pd-L1 Antibody) as Adjuvant Therapy After Definitive Local Therapy in Patients With High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck
2018-04-03
2027-06-01
Active, not recruiting
406
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Steve Biko Academic Hospital; Oncology"
#1 collaborator was "Breast International Group" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Steve Biko Academic Hospital; Oncology
According to Clinical.Site data, the most researched conditions in "Steve Biko Academic Hospital; Oncology" are
"Malignant Melanoma" (2 trials), "Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)" (1 trials) and "Lymphoma, Large B-Cell, Diffuse" (1 trials). Many other conditions were trialed in "Steve Biko Academic Hospital; Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Steve Biko Academic Hospital; Oncology
Most popular intervention types in "Steve Biko Academic Hospital; Oncology" are "Drug" (7 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (3 trials), "Placebo" (3 trials), "Carboplatin" (2 trials), "5-Fluorouracil" (1 trials) and "CHOP" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Steve Biko Academic Hospital; Oncology
The vast majority of trials in "Steve Biko Academic Hospital; Oncology" are
7 trials for "All" genders.
Clinical Trials Status at Steve Biko Academic Hospital; Oncology
Currently, there are NaN active trials in "Steve Biko Academic Hospital; Oncology".
undefined are not yet recruiting,
undefined are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Steve Biko Academic Hospital; Oncology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Steve Biko Academic Hospital; Oncology, 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".